CD8A and COVID-19: Understanding the effect of pre-existing SARS-CoV-2-derived peptide-reactive CD8+ T cells on non-symptomatic patients or prevention of COVID-19 should be important to consider the strategy for controlling pandemic or the future threat to newly arising coronaviruses.